XLCARE PHARMACEUTICALS INC - 3 LINE ITEMS FOR MONTELUKAST 10MG TABLET. AWARDED FOR A BASE YEAR OF 5/10/2026 TO 5/9/2027 PLUS 4 ONE-YEAR OPTION PERIODS.
Key Details
Description
3 LINE ITEMS FOR MONTELUKAST 10MG TABLET. AWARDED FOR A BASE YEAR OF 5/10/2026 TO 5/9/2027 PLUS 4 ONE-YEAR OPTION PERIODS.
Context & Analysis
On Jan 8, 2026, Department of Veterans Affairs to XLCARE PHARMACEUTICALS INC for 3 line items for montelukast 10mg tablet. awarded for a base year of 5/10/2026 to 5/9/2027 plus 4 one-year option periods.. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 2 offers received. The procurement used a NO SET ASIDE USED. set-aside. This award is one of several similar procurements from Department of Veterans Affairs under NAICS 325412 — related awards are listed below.
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.